Overview
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
Status:
Completed
Completed
Trial end date:
1997-06-01
1997-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)Treatments:
Atenolol
Diltiazem
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Nifedipine
Criteria
Men aand women with angiographically documented coronary artery disease, ischemia on bothstress (exercise) testing and 48-hour ambulatory electrocardiogram monitoring, and who were
amenable to revascularization.